UK markets close in 4 hours 18 minutes

Boston Scientific Corporation (0HOY.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
73.33+0.11 (+0.15%)
As of 06:49PM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.79
52-week change 338.01%
S&P500 52-week change 321.08%
52-week high 368.00
52-week low 30.00
50-day moving average 363.51
200-day moving average 355.52

Share statistics

Avg vol (3-month) 326.83k
Avg vol (10-day) 345.44k
Shares outstanding 51.38B
Implied shares outstanding 6N/A
Float 81.46B
% held by insiders 10.19%
% held by institutions 194.48%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 12.06%
Operating margin (ttm)18.88%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)14.71B
Revenue per share (ttm)10.06
Quarterly revenue growth (yoy)13.80%
Gross profit (ttm)N/A
EBITDA 3.74B
Net income avi to common (ttm)1.76B
Diluted EPS (ttm)0.53
Quarterly earnings growth (yoy)57.60%

Balance sheet

Total cash (mrq)865M
Total cash per share (mrq)0.59
Total debt (mrq)9.57B
Total debt/equity (mrq)48.99%
Current ratio (mrq)N/A
Book value per share (mrq)13.15

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A